Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01597778 · ClinicalTrials.gov registry record · Phase 3
Double Cord Versus Haploidentical (BMT CTN 1101)
A Phase 3 study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- Phase 3
- Development phase
- 368
- Enrollment target
NCT01597778 is a Phase 3 study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 368 participants.
The verdict
NCT01597778, a Phase 3 study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 368 participants
- Enrollment target
Study Summary
Hematopoietic cell transplants (HCT)are one treatment option for people with leukemia or lymphoma. Family members,unrelated donors or banked umbilical cordblood units with similar tissue type can be used for HCT. This study will compare the effectiveness of two new types of bone marrow transplants in people with leukemia or lymphoma: one that uses bone marrow donated from family members with only partially matched bone marrow; and, one that uses two partially matched cord blood units.
Interventions
- BIOLOGICAL Haploidentical Bone Marrow Transplant
- BIOLOGICAL Double Umbilical Cord Blood Transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 368 participants |
| Start Date | 2012-06 |
| Est. Completion | 2020-09-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01597778
The ClinicalTrials.gov registry entry for NCT01597778 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 368 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Haploidentical Bone Marrow Transplant is the first listed.
NCT01597778 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01597778 about?
NCT01597778 is a clinical study titled "Double Cord Versus Haploidentical (BMT CTN 1101)". Hematopoietic cell transplants (HCT)are one treatment option for people with leukemia or lymphoma. Family members,unrelated donors or banked umbilical cordblood units with similar tissue type can be used for HCT. This study will compare the effectiveness of two new types of bone marrow transplants i...
What is the current status of trial NCT01597778?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 368 participants. The study started on 2012-06. Estimated completion is 2020-09-11.
What interventions are being tested in trial NCT01597778?
The interventions under investigation include: Haploidentical Bone Marrow Transplant (BIOLOGICAL), Double Umbilical Cord Blood Transplant (BIOLOGICAL).
Who is sponsoring clinical trial NCT01597778?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.